Democritus University of Thrace, Alexandroupolis, Greece.
Leukemia. 2012 Jul;26(7):1638-46. doi: 10.1038/leu.2012.3. Epub 2012 Jan 6.
We performed an immunogenetic analysis of 345 IGHV-IGHD-IGHJ rearrangements from 337 cases with primary splenic small B-cell lymphomas of marginal-zone origin. Three immunoglobulin (IG) heavy variable (IGHV) genes accounted for 45.8% of the cases (IGHV1-2, 24.9%; IGHV4-34, 12.8%; IGHV3-23, 8.1%). Particularly for the IGHV1-2 gene, strong biases were evident regarding utilization of different alleles, with 79/86 rearrangements (92%) using allele ()04. Among cases more stringently classified as splenic marginal-zone lymphoma (SMZL) thanks to the availability of splenic histopathological specimens, the frequency of IGHV1-2()04 peaked at 31%. The IGHV1-2()04 rearrangements carried significantly longer complementarity-determining region-3 (CDR3) than all other cases and showed biased IGHD gene usage, leading to CDR3s with common motifs. The great majority of analyzed rearrangements (299/345, 86.7%) carried IGHV genes with some impact of somatic hypermutation, from minimal to pronounced. Noticeably, 75/79 (95%) IGHV1-2()04 rearrangements were mutated; however, they mostly (56/75 cases; 74.6%) carried few mutations (97-99.9% germline identity) of conservative nature and restricted distribution. These distinctive features of the IG receptors indicate selection by (super)antigenic element(s) in the pathogenesis of SMZL. Furthermore, they raise the possibility that certain SMZL subtypes could derive from progenitor populations adapted to particular antigenic challenges through selection of VH domain specificities, in particular the IGHV1-2(*)04 allele.
我们对 337 例原发性脾脏边缘区小 B 细胞淋巴瘤的 345 个 IGHV-IGHD-IGHJ 重排进行了免疫遗传学分析。3 种免疫球蛋白(IG)重链可变(IGHV)基因占 45.8%(IGHV1-2,24.9%;IGHV4-34,12.8%;IGHV3-23,8.1%)。特别是 IGHV1-2 基因,在不同等位基因的利用上存在明显的偏向,79/86 个重排(92%)使用等位基因 ()04。在由于获得脾脏组织病理学标本而被更严格归类为脾脏边缘区淋巴瘤(SMZL)的病例中,IGHV1-2()04 的频率高达 31%。IGHV1-2()04 重排的互补决定区 3(CDR3)明显长于所有其他病例,并显示出偏向的 IGHD 基因利用,导致具有共同基序的 CDR3。分析的绝大多数重排(299/345,86.7%)携带具有一定体细胞超突变影响的 IGHV 基因,从最小到显著。值得注意的是,75/79(95%)IGHV1-2()04 重排发生突变;然而,它们大多数(75 例中有 56 例;74.6%)携带少数(97-99.9% 种系同一性)保守性质和受限分布的突变。这些 IG 受体的独特特征表明,在 SMZL 的发病机制中,存在(超)抗原成分的选择。此外,它们提出了这样一种可能性,即某些 SMZL 亚型可能源自通过选择 VH 结构域特异性,特别是 IGHV1-2(*)04 等位基因,适应特定抗原挑战的祖细胞群体。